TRBC1-targeting antibody-drug conjugates for the treatment of T cell cancers - NatureAntibody and CAR T cell therapies show promise in treating T cell cancersDevelopment of antibody-drug conjugate to target TRBC1 shows potential for improved outcomes
A simple monthly injection allows mice to live 25% longer and free from diseasesAntibody injections in mice have shown potential to increase lifespan and healthspan, resembling a significant breakthrough in aging research.